Clinical Trials Browser

Phase 2 × COVID-19 × BNT162 Vaccine × Clear all

NCT04761822 2025-08-12

SARS

Phase 2 Completed

746 enrolled 28 charts

COVID-19, Hypersensitivity, Mastocytosis, Severe Acute Respiratory Syndrome

NCT05016622 2024-07-31

Booster Dose Trial

Phase 2 Terminated

106 enrolled 39 charts

COVID-19, Neoplasms